HEALD; Robert
Patent Applications and Registrations
Patent applications and USPTO patent grants for HEALD; Robert.The latest application filed is for "heterocyclic compounds for use in the treatment of cancer".
Company Profile
6.28.27
- HEALD; Robert - Cambridge GB
- Heald; Robert - Shorewood IL US
- Heald; Robert - Harlow GB
- Heald; Robert - Sawbridgeworth GB
- Heald; Robert - Essex GB
- Heald; Robert - Harlow Essex GB
- Heald; Robert - Flex Meadow GB
- Heald; Robert - US
Patent Activity
| Patent | Date |
|---|---|
| Heterocyclic Compounds For Use In The Treatment Of Cancer App 20220298134 - BLENCOWE; Peter ; et al. | 2022-09-22 |
| Deuterated Compounds For Use In The Treatment Of Cancer App 20220259174 - BLENCOWE; Peter ; et al. | 2022-08-18 |
| Bone graft dispensing device Grant 10,709,579 - Heald , et al. | 2020-07-14 |
| Bone graft dispensing device Grant 10,271,962 - Heald , et al. | 2019-04-30 |
| Bone Graft Dispensing Device App 20190021878 - Heald; Robert ; et al. | 2019-01-24 |
| Bone Graft Dispensing Device App 20180133027 - Heald; Robert ; et al. | 2018-05-17 |
| Azaindazole compounds as inhibitors of T790M containing EGFR mutants Grant 9,951,064 - Bryan , et al. April 24, 2 | 2018-04-24 |
| Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants Grant 9,890,152 - Bryan , et al. February 13, 2 | 2018-02-13 |
| Benzoxazepin PI3K inhibitor compounds and methods of use Grant 9,670,228 - Blaquiere , et al. June 6, 2 | 2017-06-06 |
| Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20170081341 - Blaquiere; Nicole ; et al. | 2017-03-23 |
| Benzoxazepin PI3K inhibitor compounds and methods of use Grant 9,546,178 - Blaquiere , et al. January 17, 2 | 2017-01-17 |
| Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20160052933 - Blaquiere; Nicole ; et al. | 2016-02-25 |
| Aminopyrimidine Compounds As Inhibitors Of T790m Containing Egfr Mutants App 20160016948 - Bryan; Marian C. ; et al. | 2016-01-21 |
| 5-anilinoimidazopyridines and methods of use Grant 9,206,174 - Heald December 8, 2 | 2015-12-08 |
| Benzoxazepin PI3K inhibitor compounds and methods of use Grant 9,198,918 - Blaquiere , et al. December 1, 2 | 2015-12-01 |
| Benzoxepin PI3K inhibitor compounds and methods of use Grant 9,175,009 - Blaquiere , et al. November 3, 2 | 2015-11-03 |
| Benzoxazepin compounds selective for PI3K P110 delta and methods of use Grant 9,090,628 - Heffron , et al. July 28, 2 | 2015-07-28 |
| Benzoxepin Pi3k Inhibitor Compounds And Methods Of Use App 20150094347 - Blaquiere; Nicole ; et al. | 2015-04-02 |
| Benzoxepin PI3K inhibitor compounds and methods of use Grant 8,952,043 - Blaquiere , et al. February 10, 2 | 2015-02-10 |
| Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20140288047 - Blaquiere; Nicole ; et al. | 2014-09-25 |
| Benzoxazepin PI3K inhibitor compounds and methods of use Grant 8,785,626 - Blaquiere , et al. July 22, 2 | 2014-07-22 |
| Benzoxepin Pi3k Inhibitor Compounds And Methods Of Use App 20140135308 - Blaquiere; Nicole ; et al. | 2014-05-15 |
| Benzoxepin PI3K inhibitor compounds and methods of use Grant 8,673,952 - Blaquiere , et al. March 18, 2 | 2014-03-18 |
| Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20140058098 - Blaquiere; Nicole ; et al. | 2014-02-27 |
| Heterocyclic compounds and methods of use Grant 8,653,089 - Heald , et al. February 18, 2 | 2014-02-18 |
| Benzoxazepin PI3K inhibitor compounds and methods of use Grant 8,586,574 - Blaquiere , et al. November 19, 2 | 2013-11-19 |
| Azaindolizines and methods of use Grant 8,486,963 - Price , et al. July 16, 2 | 2013-07-16 |
| 5-anilinoimidazopyridines And Methods Of Use App 20130150584 - Price; Stephen ; et al. | 2013-06-13 |
| Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20130079331 - Blaquiere; Nicole ; et al. | 2013-03-28 |
| Benzoxepin Pi3k Inhibitor Compounds And Methods Of Use App 20130012488 - Blaquiere; Nicole ; et al. | 2013-01-10 |
| Benzoxazepin PI3K inhibitor compounds and methods of use Grant 8,343,955 - Blaquiere , et al. January 1, 2 | 2013-01-01 |
| 5-anilinoimidazopyridines And Methods Of Use App 20120309765 - Price; Stephen ; et al. | 2012-12-06 |
| 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents Grant 8,293,763 - Price , et al. October 23, 2 | 2012-10-23 |
| 5-anilinoimidazopyridines and methods of use Grant 8,288,408 - Price , et al. October 16, 2 | 2012-10-16 |
| Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20120244149 - Blaquiere; Nicole ; et al. | 2012-09-27 |
| Benzoxazepin Compounds Selective For Pi3k P110 Delta And Methods Of Use App 20120245144 - Heffron; Timothy ; et al. | 2012-09-27 |
| Benzoxepin PI3K inhibitor compounds and methods of use Grant 8,263,633 - Blaquiere , et al. September 11, 2 | 2012-09-11 |
| Benzoxazepin P13K inhibitor compounds and methods of use Grant 8,242,104 - Blaquiere , et al. August 14, 2 | 2012-08-14 |
| Heterocyclic Compounds And Methods Of Use App 20120202785 - Heald; Robert ; et al. | 2012-08-09 |
| 5-anilinoimidazopyridines And Methods Of Use App 20110158990 - Price; Stephen ; et al. | 2011-06-30 |
| Azaindolizines And Methods Of Use App 20110142826 - Price; Stephen ; et al. | 2011-06-16 |
| 5-anilinoimidazo[1,5-a]-pyridines inhibitors of MEK kinase Grant 7,923,456 - Price , et al. April 12, 2 | 2011-04-12 |
| Benzoxazepin Pi3k Inhibitor Compounds And Methods Of Use App 20110076292 - Blaquiere; Nicole ; et al. | 2011-03-31 |
| Benzoxepin Pi3k Inhibitor Compounds And Methods Of Use App 20110076291 - Blaquiere; Nicole ; et al. | 2011-03-31 |
| 8-anilinoimidazopyridines And Their Use As Anti-cancer And/or Anti-inflammatory Agents App 20100280063 - Price; Stephen ; et al. | 2010-11-04 |
| 5-anilinoimidazopyridines And Methods Of Use App 20100004269 - Price; Stephen ; et al. | 2010-01-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 